480 related articles for article (PubMed ID: 34365056)
1. Comparative insights into multiple drug resistance determinants in Stenotrophomonas maltophilia MER1.
Xie L; Zhou A; Zhao J; Tang Y; Zhao R; Zhou Y; Cao G; Zhong C; Li J
J Glob Antimicrob Resist; 2021 Dec; 27():20-25. PubMed ID: 34365056
[TBL] [Abstract][Full Text] [Related]
2. Detection of multidrug resistant environmental isolates of
Govender R; Amoah ID; Kumari S; Bux F; Stenström TA
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2021; 56(2):213-225. PubMed ID: 33378222
[No Abstract] [Full Text] [Related]
3. Emergence of colistin-resistant Stenotrophomonas maltophilia with high virulence in natural aquatic environments.
Zhang T; Wu H; Ma C; Yang Y; Li H; Yang Z; Zhou S; Shi D; Chen T; Yang D; Li J; Jin M
Sci Total Environ; 2024 Jul; 933():173221. PubMed ID: 38750746
[TBL] [Abstract][Full Text] [Related]
4. A multidrug-resistant
Kumwenda GP; Kasambara W; Chizani K; Phiri A; Banda A; Choonara F; Lichapa B
Malawi Med J; 2021 Jun; 33(2):82-84. PubMed ID: 34777703
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
Wei C; Ni W; Cai X; Zhao J; Cui J
PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
[TBL] [Abstract][Full Text] [Related]
6. Multidrug-resistant Stenotrophomonas maltophilia in residential aged care facilities: An emerging threat.
Sapula SA; Hart BJ; Siderius NL; Amsalu A; Blaikie JM; Venter H
Microbiologyopen; 2024 Jun; 13(3):e1409. PubMed ID: 38682784
[TBL] [Abstract][Full Text] [Related]
7. Co-Occurrence of Colistin and Meropenem Resistance Determinants in a Stenotrophomonas Strain Isolated from Sewage Water.
Li J; Liu S; Fu J; Yin J; Zhao J; Zhong C; Cao G
Microb Drug Resist; 2019 Apr; 25(3):317-325. PubMed ID: 30864883
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Peptide Exposure Selects for Resistant and Fit Stenotrophomonas maltophilia Mutants That Show Cross-Resistance to Antibiotics.
Blanco P; Hjort K; Martínez JL; Andersson DI
mSphere; 2020 Sep; 5(5):. PubMed ID: 32999081
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomics analysis of
Li Y; Liu X; Chen L; Shen X; Wang H; Guo R; Li X; Yu Z; Zhang X; Zhou Y; Fu L
Front Cell Infect Microbiol; 2023; 13():1266295. PubMed ID: 38089814
[TBL] [Abstract][Full Text] [Related]
10. Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms.
Jia W; Wang J; Xu H; Li G
Int J Environ Res Public Health; 2015 May; 12(5):5177-95. PubMed ID: 25985315
[TBL] [Abstract][Full Text] [Related]
11. Characteristic antimicrobial resistance of clinically isolated Stenotrophomonas maltophilia CYZ via complete genome sequence.
Ma J; Feng J; Shan Y; Zhao Y; Qiao H; Xie L; Lin X; Wang C; Chuai X
J Glob Antimicrob Resist; 2020 Dec; 23():186-193. PubMed ID: 33011310
[TBL] [Abstract][Full Text] [Related]
12. Multidrug-resistant Stenotrophomonas maltophilia: Description of new MLST profiles and resistance and virulence genes using whole-genome sequencing.
Rizek CF; Jonas D; Garcia Paez JI; Rosa JF; Perdigão Neto LV; Martins RR; Moreno LZ; Rossi Junior A; Levin AS; Costa SF
J Glob Antimicrob Resist; 2018 Dec; 15():212-214. PubMed ID: 30036694
[TBL] [Abstract][Full Text] [Related]
13. Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system.
Zhang L; Li XZ; Poole K
Antimicrob Agents Chemother; 2000 Feb; 44(2):287-93. PubMed ID: 10639352
[TBL] [Abstract][Full Text] [Related]
14. Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients.
Wang CH; Yu CM; Hsu ST; Wu RX
J Hosp Infect; 2020 Jan; 104(1):46-52. PubMed ID: 31505224
[TBL] [Abstract][Full Text] [Related]
15. Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia.
Delgado-Valverde M; Conejo MDC; Serrano L; Fernández-Cuenca F; Pascual Á
J Antimicrob Chemother; 2020 Jul; 75(7):1840-1849. PubMed ID: 32277821
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of antimicrobial resistance in
Gil-Gil T; Martínez JL; Blanco P
Expert Rev Anti Infect Ther; 2020 Apr; 18(4):335-347. PubMed ID: 32052662
[No Abstract] [Full Text] [Related]
17. Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing.
Gülmez D; Cakar A; Sener B; Karakaya J; Hasçelik G
J Infect Chemother; 2010 Oct; 16(5):322-8. PubMed ID: 20449623
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms and phenotypic consequences of acquisition of tigecycline resistance by Stenotrophomonas maltophilia.
Blanco P; Corona F; Martinez JL
J Antimicrob Chemother; 2019 Nov; 74(11):3221-3230. PubMed ID: 31369109
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas maltophilia isolates.
Church D; Lloyd T; Peirano G; Pitout J
Scand J Infect Dis; 2013 Apr; 45(4):265-70. PubMed ID: 23113657
[TBL] [Abstract][Full Text] [Related]
20. Expression of Sme efflux pumps and multilocus sequence typing in clinical isolates of Stenotrophomonas maltophilia.
Cho HH; Sung JY; Kwon KC; Koo SH
Ann Lab Med; 2012 Jan; 32(1):38-43. PubMed ID: 22259777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
